GlycoMimetics Depreciation & Amortization 2011-2026 | GLYC

Annual Depreciation & Amortization GlycoMimetics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
84 K	35.2 K	153 K	207 K	265 K	271 K	279 K	275 K	264 K	191 K	191 K	159 K	133 K	99.9 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
279 K	35.2 K	186 K

Quarterly Depreciation & Amortization GlycoMimetics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	14.6 K	-	42.7 K	43.4 K	43.8 K	-	47.3 K	54.8 K	59.3 K	-	67.4 K	67.5 K	68.1 K	-	66.5 K	67.7 K	68.2 K	-	70.8 K	71.2 K	70.4 K	-	68.5 K	69.6 K	68.8 K	-	70.1 K	69.6 K	54.3 K	-	45.8 K	46.7 K	47.2 K	-	51.9 K	46.3 K	44.2 K	-	40.8 K	38.9 K	34.6 K	-	33.3 K	32.4 K	31.9 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
71.2 K	14.6 K	53.5 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akari Therapeutics, Plc AKTX	14 K	$ 3.54	-20.81 %	$ 238 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 330.34	3.6 %	$ 43.3 B	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.89	-4.33 %	$ 4.85 M	China
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
AbbVie ABBV	762 M	$ 206.69	-1.01 %	$ 366 B	USA
Aquestive Therapeutics AQST	548 K	$ 4.09	-0.97 %	$ 437 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
AbCellera Biologics ABCL	18.4 M	$ 3.39	-3.69 %	$ 1.01 B	Canada
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 8.22	2.37 %	$ 225 M	Israel
Ardelyx ARDX	3.06 M	$ 5.97	0.51 %	$ 1.44 B	USA
Cerevel Therapeutics Holdings CERE	5.63 M	-	-	$ 7.29 B	USA
Akebia Therapeutics AKBA	1.27 M	$ 1.32	-4.35 %	$ 339 M	USA